Immunohistochemical expression of SOX2 in non-melanoma skin cancer.

Asmaa Gaber AbdouAmal Farid MostafaSamar GafarAzza Gaber Antar Farag

Published in: Journal of cosmetic dermatology (2021)

SOX2 was over-expressed in cutaneous SCC and BCC without a significant difference. SOX2 may enhance progression of NMSC manifested by its association with large tumor size and advanced stage.

Keyphrases

skin cancer
transcription factor
stem cells
poor prognosis
binding protein
long non coding rna